🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 7 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/02/2018 31,45 32,00 29,35 30,15 -16,48% 8,43% 3.918.200
15/02/2018 36,10 36,10 36,10 36,10 +0,00% 0,00% 401.000
14/02/2018 35,45 36,50 34,75 36,10 +0,56% 4,94% 645.600
13/02/2018 37,10 37,20 35,60 35,90 -1,24% 4,31% 1.109.500
12/02/2018 37,55 40,25 35,05 36,35 -2,81% 13,85% 3.059.000
09/02/2018 36,35 38,45 35,90 37,40 +4,47% 7,02% 1.505.300
08/02/2018 38,15 39,10 35,40 35,80 -5,79% 9,70% 1.588.400
07/02/2018 37,60 39,20 37,60 38,00 +1,06% 4,26% 810.800
06/02/2018 36,40 38,35 36,40 37,60 +1,08% 5,36% 584.200
05/02/2018 38,15 39,65 36,90 37,20 -3,38% 7,21% 1.276.500
02/02/2018 38,35 39,80 37,80 38,50 -1,16% 5,22% 1.916.300
01/02/2018 36,20 39,65 36,00 38,95 +7,01% 10,08% 1.438.800
31/01/2018 36,60 36,95 35,35 36,40 -0,14% 4,37% 1.131.000
30/01/2018 37,45 37,75 36,40 36,45 -4,20% 3,60% 648.900
29/01/2018 39,70 40,00 37,85 38,05 -5,35% 5,42% 1.052.000
26/01/2018 38,90 40,40 38,40 40,20 +4,01% 5,14% 826.900
25/01/2018 39,10 39,10 38,05 38,65 -0,77% 2,69% 576.000
24/01/2018 39,00 39,20 38,00 38,95 -0,26% 3,08% 621.700
23/01/2018 39,30 39,60 38,85 39,05 -0,76% 1,91% 487.000
22/01/2018 38,85 39,70 38,55 39,35 +1,55% 2,96% 782.800
19/01/2018 39,40 39,40 37,50 38,75 -0,90% 4,82% 1.014.100
18/01/2018 40,10 40,65 39,00 39,10 -2,98% 4,11% 706.600
17/01/2018 40,45 40,90 39,80 40,30 +0,00% 2,72% 514.100
16/01/2018 41,45 41,85 40,25 40,30 -2,89% 3,86% 495.300
12/01/2018 42,65 43,15 41,05 41,50 -1,73% 4,92% 1.031.800
11/01/2018 41,75 42,50 41,50 42,23 +1,76% 2,40% 739.400
10/01/2018 42,35 42,35 37,95 41,50 -2,92% 10,39% 1.651.900
09/01/2018 42,70 43,80 42,65 42,75 +0,12% 2,69% 486.000
08/01/2018 42,50 43,20 41,70 42,70 +0,59% 3,53% 521.400
05/01/2018 42,80 42,80 41,25 42,45 -1,05% 3,62% 752.700